Three researchers from Type 1 Diabetes TrialNet—Diane K. Wherrett, MD, FRCPC, S. Alice Long, PhD, and Laura M. Jacobsen, MD—will review the latest research on immune therapy for type 1 diabetes during a two-hour virtual symposium Tuesday morning. TrialNet is an international network of academic institutions, endocrinologists, physicians, scientists, and health care teams dedicated to type 1 diabetes research.

Read More